- Home
- /
- News
- /
- Target Identification/ Validation
- /
- December 2010
Target Identification/ Validation News for December 2010
Company will provide open access to its rAAV GENESIS human gene-editing platform as part of strategy to generate 2500 new in vitro models of cancer, neurodegenerative cardiovascular and infectious diseases.
14 December, 2010